GuidelineJournal of clinical hypertension (Greenwich, Conn.)2008
ASH position paper: treatment of hypertension in patients with diabetes-an update.
Guideline in Journal of clinical hypertension (Greenwich, Conn.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- The Use of a Stem and Leaf Aqueous Extract of Cissus quadrangularis (CQR-300) to Reduce Body Fat and Other Components of Metabolic Syndrome in Overweight Participants.Journal of alternative and complementary medicine (New York, N.Y.) · 2019Trial
- Fixed-Combination Olmesartan/Amlodipine Was Superior to Perindopril + Amlodipine in Reducing Central Systolic Blood Pressure in Hypertensive Patients With Diabetes.Journal of clinical hypertension (Greenwich, Conn.) · 2016Trial
- Comparison of aliskiren/hydrochlorothiazide combination therapy and amlodipine monotherapy in patients with stage 2 systolic hypertension and type 2 diabetes mellitus.Journal of clinical hypertension (Greenwich, Conn.) · 2011Trial
- Seated cuff blood pressure-lowering efficacy of an olmesartan medoxomil-based treatment regimen in patients with type 2 diabetes mellitus.Drugs in R&D · 2011Trial
- Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial.Diabetes care · 2011Trial
- The prevalence of pre-diabetes and diabetes and their associated factors in Northeast China: a cross-sectional study.Scientific reports · 2019Article
- Determinants of drug-related problems among ambulatory type 2 diabetes patients with hypertension comorbidity in Southwest Ethiopia: a prospective cross sectional study.BMC research notes · 2018Article
- Determinants of isolated systolic hypertension among diabetic patients visiting the diabetic clinic at the Tamale Teaching Hospital, Northern Ghana.African health sciences · 2016Article
- Type of β-blocker use among patients with versus without diabetes after myocardial infarction.American heart journal · 2014Article
- Article
- Best strategies for hypertension management in type 2 diabetes and obesity.Current diabetes reports · 2010Review
- The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.The Medical clinics of North America · 2009Review
- ADVANCE: blood pressure lowering in diabetes.Journal of clinical hypertension (Greenwich, Conn.) · 2009Article
- Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.Progress in cardiovascular diseasesReview
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This report updates concepts on hypertension management in patients with diabetes. It focuses on clinical outcomes literature published within the last 3 years and incorporates these observations into modifications of established guidelines. While the fundamentals of treatment and goal blood pressures remain unchanged, approaches to specific patient-related issues has changed. This update focuses on questions such as what to do when a patient has an elevated potassium level when therapy is initiated and whether combinations of agents that block the renin-angiotensin system still be used. In addition, there are updates from trials, just published and in press, that focus on related management issues influencing cardiovascular outcomes in persons with diabetes. Last, an updated algorithm is provided that incorporates many of the new findings and is suggested as a starting point to achieve blood pressure goals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.